Searched over 200M research papers
10 papers analyzed
These studies suggest that losartan primarily improves hemodynamic effects and blood pressure but does not directly lower heart rate.
20 papers analyzed
Losartan, an angiotensin II receptor antagonist, is widely used for managing hypertension and heart failure. One of the key questions surrounding its use is whether it can lower heart rate. This article synthesizes findings from multiple studies to provide a clear understanding of losartan's effects on heart rate.
Several studies have investigated the hemodynamic effects of losartan in patients with heart failure. A notable study demonstrated that losartan significantly reduced heart rate in patients with symptomatic heart failure over a 12-week period. This reduction was observed across various dosages, with the most pronounced effects seen at higher doses (25 mg and 50 mg).
In patients with ischemic cardiomyopathy and heart failure, losartan has been shown to improve heart rate variability (HRV) and heart rate turbulence, which are critical indicators of cardiac autonomic function. A 12-week study found significant improvements in HRV parameters and a decrease in turbulence onset, indicating a stabilizing effect on heart rate.
A comparative trial assessed the effects of losartan, verapamil, and enalapril on blood pressure and heart rate. While verapamil was more effective in lowering heart rate over a 24-hour period, losartan did not significantly alter heart rate compared to placebo. This suggests that while losartan has beneficial effects on blood pressure, its impact on heart rate may be less pronounced compared to other antihypertensives like verapamil.
In studies involving non-human primates, losartan did not significantly alter heart rate, even though it effectively blocked angiotensin II-induced pressor responses and reduced blood pressure. This finding aligns with observations in human studies where losartan's primary effects were on blood pressure rather than heart rate.
In healthy male volunteers, losartan administration resulted in significant decreases in blood pressure but did not lead to notable changes in heart rate. This further supports the notion that losartan's primary cardiovascular effects are on blood pressure modulation rather than direct heart rate reduction.
Chronic administration of losartan in spontaneously hypertensive rats showed that while it effectively lowered blood pressure, it did not significantly alter the baroreceptor reflex control of heart rate. This indicates that losartan's impact on heart rate may be mediated through indirect mechanisms rather than direct modulation of heart rate.
In patients with essential hypertension and type 2 diabetes mellitus, losartan treatment over 12 weeks led to improvements in HRV, suggesting enhanced cardiac vagal activity and reduced sympathetic activity. This indicates a potential benefit of losartan in improving autonomic control of heart rate in this patient population.
In summary, while losartan has significant effects on blood pressure and provides various cardiovascular benefits, its impact on lowering heart rate is less consistent and may depend on the patient population and specific conditions. In heart failure patients, losartan can reduce heart rate and improve heart rate variability, but in other populations, its primary effects remain on blood pressure modulation. Further research is needed to fully elucidate the conditions under which losartan can effectively lower heart rate.
Most relevant research papers on this topic